Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic ancestry-concordant ceramide metabolism and response to androgen receptor pathway inhibition in metastatic castration-resistant prostate cancer.

Cancer·2026
Same author

Rethinking the role of synergy calculations in the next century of drug combination discovery.

Med (New York, N.Y.)·2026
Same author

A Conserved Enhancer Locus in Extrachromosomal DNA and Homogeneously Staining Regions Activates MYC Transcription in Group 3 Medulloblastoma.

Cancer research·2026
Same author

Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomes.

Cell reports. Medicine·2026
Same author

CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer.

Oncotarget·2026
Same author

Uncovering the genomic complexity of PAX5 intragenic tandem multiplication via long-read and short-read sequencing.

Blood·2026

Related Experiment Video

Updated: May 1, 2026

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
07:37

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects

Published on: January 9, 2020

9.7K

Integrative "omic" analysis for tamoxifen sensitivity through cell based models.

Liming Weng1, Dana Ziliak1, Bonnie Lacroix1

  • 1Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, United States of America.

Plos One
|April 5, 2014
PubMed
Summary
This summary is machine-generated.

This study identified genetic variants and microRNA expressions impacting tamoxifen sensitivity in African-derived samples. These findings reveal potential pharmacogenomic biomarkers for personalized breast cancer treatment.

More Related Videos

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.2K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.3K

Related Experiment Videos

Last Updated: May 1, 2026

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
07:37

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects

Published on: January 9, 2020

9.7K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.2K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.3K

Area of Science:

  • Pharmacogenomics
  • Genetics
  • Molecular Biology

Background:

  • Tamoxifen sensitivity in breast cancer patients varies, with reported ethnic differences between Caucasian and African American populations.
  • Most previous research on tamoxifen therapy has focused on Caucasian individuals, necessitating a broader investigation into other ethnic groups.

Purpose of the Study:

  • To comprehensively evaluate genetic variants associated with tamoxifen therapy in African-derived samples.
  • To investigate the relationships among endoxifen sensitivity, single nucleotide polymorphism (SNP) genotype, mRNA, and microRNA expressions using an integrative "omic" approach.

Main Methods:

  • Utilized an integrative "omic" approach on 58 HapMap Yoruba (YRI) lymphoblastoid cell lines.
  • Identified associations between 50 SNPs, 34 genes, and 30 microRNAs with cellular sensitivity to endoxifen (tamoxifen's active metabolite).
  • Validated findings in breast cancer cell lines, including the correlation of TRAF1 expression with tamoxifen sensitivity.

Main Results:

  • Discovered 50 SNPs associated with endoxifen sensitivity, affecting gene and microRNA expression.
  • Identified genetic and microRNA findings common to both Caucasian and African samples, as well as unique associations in African samples.
  • Confirmed the roles of TRAF1 and hsa-let-7i in enhancing tamoxifen sensitivity through experimental validation.

Conclusions:

  • Integrative "omic" analysis successfully identified pharmacogenomic biomarkers potentially influencing tamoxifen sensitivity.
  • Findings highlight ethnic-specific genetic factors and shared pathways affecting tamoxifen response.
  • The study provides a foundation for developing personalized tamoxifen therapies based on genetic profiles.